Here are five key notes:
1. Life Spine’s sales grew 45 percent over the past six months.
2. The growth is due to a reorganized and driven sales force focusing on exclusive distributorships as well as new procedure solutions.
3. The company plans to release several new products this year, which could lead to further sales increases going forward.
4. The FDA recently cleared Life Spine’s PROLIFT Expandable Interbody System, which is the most recent addition to the company’s PROLIFT expandable interbody technology. The system will be released on the full market later this year.
5. Last year, Life Spine achieved FDA clearance for the Gruve Anterior Cervical Plate System and released the Expandable Lumbar Interbody Fusion System as well as the SIMPACT Sacroiliac Joint Fixation System.
More articles on orthopedic devices:
Titan Spine executive named to FDA-sponsored medical device initiative: 5 key notes
K2M’s Eric Major receives 2016 Medallion for Entrepreneurship: 5 things to know
Zimmer Biomet receives $380M+ supply order from US defense department: 3 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
